Immunovia publ AB (IMMNOV) — Working Capital to Net Assets Ratio
Immunovia publ AB (IMMNOV) has a Working Capital to Net Assets ratio of 84.6% as of March 2026. Working capital of Skr39.32 Million (current assets of Skr58.52 Million minus current liabilities of Skr19.20 Million) is measured against net assets of Skr46.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Immunovia publ AB (IMMNOV) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Immunovia publ AB Working Capital to Net Assets (2012–2025)
This chart shows how Immunovia publ AB's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 84.6%, reflecting working capital of Skr39.32 Million against net assets of Skr46.50 Million SEK. See Immunovia publ AB (IMMNOV) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Immunovia publ AB (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Immunovia publ AB from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see IMMNOV stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | Skr64.71 Million | Skr64.73 Million | Skr80.41 Million | Skr15.69 Million | ▲ +38.1 pp |
| 2024 | 61.8% | Skr7.20 Million | Skr11.65 Million | Skr28.59 Million | Skr21.39 Million | ▼ -13.7 pp |
| 2023 | 75.5% | Skr50.61 Million | Skr66.99 Million | Skr80.51 Million | Skr29.90 Million | ▲ +38.0 pp |
| 2022 | 37.5% | Skr91.53 Million | Skr243.80 Million | Skr115.61 Million | Skr24.09 Million | ▼ -23.4 pp |
| 2021 | 60.9% | Skr264.35 Million | Skr433.90 Million | Skr297.10 Million | Skr32.75 Million | ▼ -12.7 pp |
| 2020 | 73.6% | Skr441.01 Million | Skr599.40 Million | Skr474.80 Million | Skr33.79 Million | ▲ +6.3 pp |
| 2019 | 67.3% | Skr240.52 Million | Skr357.61 Million | Skr269.16 Million | Skr28.64 Million | ▼ -15.7 pp |
| 2018 | 82.9% | Skr383.14 Million | Skr461.95 Million | Skr398.57 Million | Skr15.43 Million | ▲ +2.7 pp |
| 2017 | 80.3% | Skr190.03 Million | Skr236.80 Million | Skr204.01 Million | Skr13.97 Million | ▼ -11.6 pp |
| 2016 | 91.9% | Skr254.15 Million | Skr276.63 Million | Skr260.92 Million | Skr6.78 Million | ▲ +9.2 pp |
| 2015 | 82.6% | Skr69.24 Million | Skr83.80 Million | Skr76.95 Million | Skr7.71 Million | ▲ +0.0 pp |
| 2014 | 82.6% | Skr29.53 Million | Skr35.74 Million | Skr32.66 Million | Skr3.13 Million | ▲ +55.4 pp |
| 2013 | 27.2% | Skr1.34 Million | Skr4.94 Million | Skr3.87 Million | Skr2.53 Million | ▲ +94.2 pp |
| 2012 | -67.0% | Skr-888.33K | Skr1.33 Million | Skr783.30K | Skr1.67 Million | — |